en
lv
ru
Investors
Corporate Governance
Financial Calendar
Financial News
Presentations
Documents
Analysts
Shareholders’ Meetings
Investor contacts
Media
Latest News
Photo Library
Media Contacts
Sponsorship and support
Careers
Personnel Policy
Vacancies
Application Form
Internship
Career Contacts
Contacts
Training courses and actual information
Search
Home
Company
About Olainfarm
Business Strategy
Governance and Management
Board
Supervisory Council
Senior Executive Team
Auditing Committee
Olainfarm Worldwide
Responsibility
Video surveillance privacy statement
Licences and Certificates
Quality Policy
Environment Protection Policy
Participation in Projects
Ongoing projects
Completed projects
Procurements
Awards
History
Articles of Association
In memoriam
Products and Services
Products
Over the Counter (OTC)
Prescription Medicines
Food Supplements
APIs and Intermediates
APIs
Intermediates
Pharmacovigilance
Services
QC/QA Services
Regulatory Services
APIs and Intermediates Development
Final Dosage Forms Development
Contract Manufacturing
Research and Development
R&D of APIs and Intermediates
R&D of Final Dosage Forms
Preclinical Trials
Clinical Trials
Cooperation
Investors
MAJOR SHAREHOLDERS
Shareholding 31 December 2019
Investors
07.25.2015
Investors
Documents
Information on Shares
Dividends
Analysts
Corporate Governance
Financial Calendar
Financial News
Investor Contacts
Presentations
Shareholders’ Meetings
Search
Recent Posts
JSC Olainfarm donates funds to the National reference laboratory of Riga East Hospital for the purchase of Covid-19 analysis equipment
November 23, 2020
“Olainfarm” confirmed the compliance with Russian Good Manufacturing Practice (GMP)
November 2, 2020
JSC “Olainfarm” awaits its 48th anniversary with a growth strategy
October 14, 2020
The new five-year strategy of JSC Olainfarm – sustainable healthcare products and market expansion
September 2, 2020
Mārtiņš Pūriņš leaves his position as JSC Olainfarm Management Board member
July 21, 2020
